Vertex Reports First-Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Vertex Pharma (VRTX) Tops Q1 EPS by 29c, Revenues Beat
April 29, 2021 4:08 PM EDTVertex Pharma (NASDAQ: VRTX) reported Q1 EPS of $2.98, $0.29 better than the analyst estimate of $2.69. Revenue for the quarter came in at $1.72 billion versus the consensus estimate of $1.66 billion.
"In CF, our goal is that all eligible patients have access to and can... More
